Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player.  Cubist has received upgrades from several brokers.  At present, cubist satisfies ...
Read more »